Stock Information
Stock Symbol: LNAI
Stock Exchange: NASDAQ
Company Name: Lunai Bioworks Inc.
Sector: Healthcare / Biotechnology
Focus: AI-Powered Drug Discovery, Biodefense and Advanced Diagnostics
Analysis Basis: LNAI is analyzed using the supplied 1-minute chart, EMA20, EMA50, EMA100, EMA200, RSI, RVOL, CMF, buying pressure, breakout structure, support, resistance and price targets.
Quick Technical Snapshot
$1.32
Current Chart Price
$1.67
Visible High
$0.90
Visible Low
70 / 100
Breakout Score
- Displayed Open: $1.19
- Displayed High: $1.32
- Displayed Low: $1.19
- Displayed Close: $1.32
- Displayed Candle Change: approximately +7.76%
- Current Price: $1.32
- Visible Chart High: $1.67
- Visible Chart Low: $0.90
- Breakout Score: 70 / 100
- Bottom Score: 25 / 100
- RSI: approximately 66.3
- RVOL: approximately 0.4×
- CMF: approximately +0.42
- Buy / Sell Ratio: approximately 6.0×
- Previous Bottom: $1.04
- Breakout Midpoint: $1.14
- Breakout Stop: $1.13
- Target 1: $1.17
- Target 2: $1.20
- Breakout Price: $1.24
- Required Volume: approximately 538
EMA Recovery Status
The supplied dashboard shows LNAI at Stage 4 of 5 with a major directional improvement.
The stock has successfully reclaimed:
- EMA20
- EMA50
- EMA100
- EMA200
The next major technical requirement is for the moving averages themselves to become properly stacked in bullish order.
Key EMA Levels
$1.29
EMA200
$1.18
EMA100
$1.16
EMA50
$1.32
Current Price
The most important technical development is the move above EMA200 near $1.29.
EMA200 often acts as a major trend filter. A stock recovering above this level can attract additional technical attention.
Holding above $1.29 would therefore help preserve the current bullish recovery structure.
Breakout Level: $1.24
The dashboard identifies approximately $1.24 as the primary breakout price.
The current price near $1.32 is already above this level.
This means the immediate breakout has occurred according to the supplied model.
The next question is whether LNAI can hold the breakout and continue above EMA200.
Breakout Midpoint: $1.14
The breakout midpoint is approximately $1.14.
This level can now act as a deeper technical support reference.
A move back below this region would significantly weaken the current momentum structure.
Breakout Failure Level: $1.13
The dashboard identifies approximately $1.13 as the breakout stop or failure level.
The current price is substantially above it.
A sustained break below $1.13 would invalidate much of the recent breakout structure.
LNAI Support, Resistance and Price Targets
Support Levels
- $1.29 — EMA200 support
- $1.24 — breakout level
- $1.20 — previous target / support area
- $1.18 — EMA100
- $1.16 — EMA50
- $1.14 — breakout midpoint
- $1.13 — failure level
- $1.04 — previous bottom
- $0.90 — major visible low
Resistance Levels
- $1.35 — immediate resistance zone
- $1.40 — short-term resistance
- $1.45-$1.50 — prior supply zone
- $1.55-$1.60 — upper resistance
- $1.67 — visible chart high
- $1.70 — psychological resistance
Technical Roadmap
- Hold: $1.29
- Breakout Base: $1.24
- Immediate Test: $1.35
- Next Zone: $1.40-$1.50
- Major High: $1.67
RSI: 66.3
The dashboard displays RSI near 66.3.
This indicates strong bullish momentum without yet showing an extreme overbought reading above 70.
RSI holding in the 60-70 area while price remains above EMA200 would support continued momentum.
CMF Money Flow: +0.42
CMF near +0.42 is a notably positive reading.
It suggests strong accumulation and positive underlying money flow.
Positive CMF combined with a price above EMA200 is one of the strongest features of the current setup.
Buying Power vs Selling Power
The dashboard displays a buy-to-sell ratio near 6.0×.
This indicates that buying pressure is significantly stronger than selling pressure.
This reading supports the bullish breakout structure, although stronger RVOL would add confirmation.
Relative Volume – RVOL
RVOL is approximately 0.4×.
This means relative trading volume remains below the model's comparison baseline.
This is currently one of the main weaknesses in the setup.
For a stronger continuation, LNAI would ideally show a meaningful increase in volume.
Breakout Score: 70 / 100
The dashboard gives LNAI a breakout score of 70 / 100.
Positive factors include:
- Price above EMA20.
- Price above EMA50.
- Price above EMA100.
- Price above EMA200.
- CMF near +0.42.
- Buy / sell ratio near 6.0×.
- RSI near 66.3.
- Price above the $1.24 breakout level.
Main weakness:
- RVOL remains only around 0.4×.
- Moving averages are not yet fully stacked in bullish order.
About Lunai Bioworks Inc.
Lunai Bioworks Inc. is a biotechnology company focused on AI-powered drug discovery, biodefense and advanced diagnostics.
Its strategy combines artificial intelligence, computational biology and biological-data analysis.
Lunai Bioworks Inc. trades on Nasdaq under the ticker LNAI.
AI-Powered Drug Discovery
Lunai's technology strategy focuses on using artificial intelligence to analyze complex biological data and identify potential therapeutic opportunities.
AI-enabled drug discovery can potentially improve target identification, patient segmentation and research efficiency.
Successful commercialization of these technologies could become an important long-term catalyst.
Biodefense Opportunity
Lunai also has exposure to the AI-enabled biodefense sector.
The combination of artificial intelligence, biotechnology and biosecurity creates a potentially significant specialized market opportunity.
Government partnerships, defense contracts or research collaborations could become important catalysts.
Fundamental Checklist
| Factor | What to Monitor |
|---|---|
| AI Platform | Commercial progress and validation of AI drug-discovery technology. |
| Research Programs | Progress across biotechnology and therapeutic programs. |
| Partnerships | Pharmaceutical, research and government collaborations. |
| Cash Position | Available liquidity and research funding requirements. |
| Dilution | Potential future equity issuance. |
| Revenue | Commercialization and partnership revenue. |
| Regulatory Progress | Regulatory milestones for future therapeutic programs. |
| Trading Liquidity | Volume, spreads and market participation. |
Potential Catalysts
- New pharmaceutical partnerships.
- AI drug-discovery collaborations.
- Biotechnology research milestones.
- New biodefense contracts.
- Government partnerships.
- New therapeutic targets.
- Research-validation results.
- Improved financial results.
- Higher trading volume.
- Holding above EMA200.
- Break above $1.35.
- Move toward $1.50-$1.67.
Major Risk Factors
- Small-cap biotechnology volatility.
- Low relative volume.
- Research-development risk.
- Potential clinical-development risk.
- High research and development costs.
- Potential capital raising.
- Potential shareholder dilution.
- AI-platform commercialization risk.
- Regulatory risk.
- Competition in AI biotechnology.
- High volatility after momentum spikes.
Bullish Scenario
- LNAI holds above EMA200 near $1.29.
- Price maintains the $1.24 breakout.
- CMF stays positive.
- Buy / sell pressure stays above 1.0×.
- RVOL improves.
- Price breaks $1.35.
- LNAI advances toward $1.40-$1.50.
- Momentum continues toward $1.60-$1.67.
A sustained move above $1.67 would represent a major technical expansion.
Neutral / Consolidation Scenario
LNAI may consolidate between approximately $1.20 and $1.35.
This could allow the moving averages to improve their bullish alignment.
A constructive consolidation would ideally maintain positive CMF and support above the breakout zone.
Bearish Scenario
The first warning sign would be a loss of $1.29 and EMA200.
A decline below $1.24 would weaken the breakout.
Below $1.13-$1.14, the technical structure would deteriorate substantially.
Further weakness could expose $1.04 and eventually $0.90.
Trader's Decision Map
Stronger Setup
Hold $1.29 → maintain $1.24 breakout → break $1.35 → volume improves → target $1.40-$1.50 → challenge $1.67.
Wait
Price consolidates around $1.20-$1.35 while the moving averages attempt to form bullish alignment.
Weak Setup
Lose $1.29 → break $1.24 → lose $1.13 → move toward $1.04 and potentially $0.90.
Potential Trading Plan
- Current Price: $1.32
- EMA200: $1.29
- Breakout Level: $1.24
- Target 1: $1.35-$1.40
- Target 2: $1.45-$1.50
- Major Target: $1.60-$1.67
- EMA100: $1.18
- EMA50: $1.16
- Breakout Midpoint: $1.14
- Failure Level: $1.13
- Previous Bottom: $1.04
- Major Visible Low: $0.90
SEO Keywords
Primary Keywords:
LNAI stock,
Lunai Bioworks,
Lunai Bioworks Inc,
LNAI stock analysis,
LNAI stock today,
LNAI stock price,
LNAI stock forecast,
LNAI stock prediction,
Lunai Bioworks stock,
NASDAQ LNAI.
Technical Analysis Keywords:
LNAI technical analysis,
LNAI support and resistance,
LNAI breakout,
LNAI EMA200,
LNAI EMA100,
LNAI EMA50,
LNAI RSI,
LNAI RVOL,
LNAI CMF,
LNAI volume analysis,
LNAI price target,
LNAI breakout level,
LNAI chart analysis.
Company Keywords:
Lunai Bioworks AI,
Lunai Bioworks drug discovery,
AI biotech stock,
AI drug discovery stock,
biodefense stock,
artificial intelligence biotech,
AI healthcare stock,
biotech AI stock,
healthcare AI company,
biotechnology stock.
Long-Tail Keywords:
LNAI stock analysis today,
Lunai Bioworks stock analysis,
LNAI stock support and resistance,
LNAI stock price target,
LNAI stock breakout level,
is LNAI stock a buy,
LNAI stock forecast 2026,
LNAI technical analysis today,
LNAI stock latest news,
Lunai Bioworks AI drug discovery,
LNAI biotech stock.
Final Conclusion
LNAI currently shows a strong technical recovery structure with a breakout score of 70 / 100.
The stock is trading near $1.32 and has moved above the major EMA200 level near $1.29.
The chart also shows price above EMA50 and EMA100, which represents a major improvement from the previous bottoming structure.
CMF near +0.42 and a buy-to-sell ratio near 6.0× indicate strong accumulation and buying pressure.
RSI near 66.3 shows strong momentum without yet being deeply overbought.
The principal weakness is RVOL near 0.4×, meaning stronger trading volume would provide better breakout confirmation.
If LNAI holds above $1.29 and continues above $1.35, the chart could open toward $1.40, $1.50 and potentially the recent high near $1.67.
On the downside, a loss of $1.29 would weaken the setup, while a decline below $1.13-$1.14 would significantly damage the recent breakout structure.
Overall, LNAI currently has strong buying pressure, positive money flow, a successful breakout and a major EMA200 recovery, but higher volume would make the setup considerably stronger.
Disclaimer: This content is for informational purposes only and does not represent financial advice, a buy recommendation or a sell recommendation.
Available in the USA